Jan De Witte Integra Lifesciences Holdings Corp (IART) insider trading activity

Jan De Witte is President & CEO of INTEGRA LIFESCIENCES HOLDINGS CORP. Currently has a direct ownership of 23,902 shares of IART, which is worth approximately $533,731. The most recent transaction as insider was on Nov 01, 2024, when has been sold 4,262 shares (Common Stock) at a price of $19.28 per share, resulting in proceeds of $82,171. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.9K

30.26% 3M change

30.26% 12M change

Total Value Held $533,731

Jan De Witte Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 01 2024	SELL Payment of exercise price or tax liability	$82,171 $19.28 p/Share	4,262 Reduced 15.13%	23,902 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	-	9,814 Added 25.84%	28,164 Common Stock
Mar 11 2024	SELL Payment of exercise price or tax liability	$7,425 $36.22 p/Share	205 Reduced 1.1%	18,350 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	-	205 Added 1.09%	18,555 Common Stock
Mar 10 2024	SELL Payment of exercise price or tax liability	$12,708 $36.73 p/Share	346 Reduced 1.85%	18,350 Common Stock
Mar 10 2024	BUY Exercise of conversion of derivative security	-	346 Added 1.82%	18,696 Common Stock
Jan 18 2024	SELL Payment of exercise price or tax liability	$25,306 $42.39 p/Share	597 Reduced 3.15%	18,350 Common Stock
Jan 18 2024	BUY Exercise of conversion of derivative security	-	597 Added 3.05%	18,947 Common Stock
Nov 01 2023	SELL Payment of exercise price or tax liability	$157,054 $36.85 p/Share	4,262 Reduced 18.85%	18,350 Common Stock
Nov 01 2023	BUY Exercise of conversion of derivative security	-	9,814 Added 30.27%	22,612 Common Stock
Jun 01 2023	BUY Open market or private purchase	$299,992 $38.5 p/Share	7,792 Added 37.84%	12,798 Common Stock
Mar 11 2023	SELL Payment of exercise price or tax liability	$203,126 $52.87 p/Share	3,842 Reduced 43.42%	5,006 Common Stock
Feb 13 2023	BUY Grant, award, or other acquisition	-	8,848 Added 50.0%	8,848 Common Stock
Jan 18 2023	SELL Payment of exercise price or tax liability	$23,610 $54.78 p/Share	431 Reduced 100.0%	0 Common Stock
Jan 18 2023	BUY Exercise of conversion of derivative security	-	431 Added 50.0%	431 Common Stock

Also insider at

RSMDF

RESMED INC Healthcare

Director

JDW

Jan De Witte

President & CEO

Princeton, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IART shares.

Notify only if

Value

Insider Trading

Get notified when an Integra Lifesciences Holdings Corp insider buys or sells IART shares.

Notify only if

Operation

Value

Type

News

Receive news related to INTEGRA LIFESCIENCES HOLDINGS CORP

Track Activities on IART

Account